Laminopathies are an heterogeneous group of human disorders caused by mutations in the lamin A/C gene or in genes coding for lamin-binding proteins. They include several tissue-specific disorders (e.g., Emery-Dreifuss muscular distrophy and dilated cardiomyopathy with conduction defects) or systemic forms including the most severe phenotypes: Hutchinson-Gilford progeria syndrome (HGPS) and restrictive dermopathy (RD). 1 RD is a lethal neonatal laminopathy causing bone resorption of clavicles, tight translucent skin, anomalous facial features and arthrogryposis. 2 RD is a secondary laminopathy, since it is associated with mutations of a lamin-binding protein, the endoprotease ZMPSTE24 involved in lamin A precursor (prelamin A) post-translational processing. 3 A common mutation in the ZMPSTE24 gene (c.1085_1086InsT) has been characterized in most RD patients leading to impaired protein expression and prelamin A accumulation in cells.
Prelamin A processing consists of four steps: farnesylation of the C-terminal CaaX motif by the enzyme protein farnesyl-transferase, cleavage of the last three aminoacids by ZMPSTE24, carboxymethylation of the C-terminal cysteine by Icmt methyl-transferase and proteolytic removal of the last 18 aminoacids by ZMPSTE24. Thus, four processing intermediates are formed during prelamin A maturation. 4 Since also the RCE1 endoprotease catalyses the first cleavage step, 3 ZMPSTE24 absence should cause accumulation of farnesylated-carboxymethylated prelamin A.
Accumulation of different prelamin A forms causes different effects on nuclear organization: 5,6 accumulating farnesylated prelamin A causes nuclear enlargement and mis-shapening, along with changes in the localization pattern of heterochromatin-associated proteins HP1 and tri-H3K9, 7 while accumulating non-farnesylated prelamin A produces intranuclear prelamin A and heterochromatin clusters, with re-localization of heterochromatin markers, without nuclear enlargement. 5 Also, impaired lamin maturation promotes DNA damage accumulation. 8, 9 We analyzed prelamin A processing in four different RD cell lines bearing the same ZMPSTE24 mutation 2 using an antibody (Sc-6214) directed to a C-terminal epitope of prelamin A. 10 The experiments were performed at low (5) (6) (7) (8) (9) (10) (11) (12) and at high (16-22) culture passage numbers.
Low passage RD cells showed high prelamin A levels, but undetectable mature lamin A; prelamin A was localized exclusively at the nuclear rim by both immunofluorescence and colloidal goldimmunoelectron microscopy; western blot analysis confirmed this data (part A). TEM analysis showed severe nuclear morphology defects (enlarged size, envelope invaginations) and heterochromatin disorganization (areas devoid of heterochromatin) in 10-30% of cells, while most of RD nuclei were normally shaped, though presented nuclear envelope duplications and severe heterochromatin loss (part A). Surprisingly, at high passage numbers, labeling by Sc-6214 was reduced in about 90% of nuclei and undetectable in several cells; only highly dysmorphic nuclei showed intense prelamin A staining. Ultrastructural analysis of high passage fibroblasts revealed improved peripheral heterochromatin organization in 50% of the normally shaped nuclei and peripheral heterochromatin clumps in 5% of nuclei. At this stage (p.16-22), western blot analysis revealed prelamin A as a doublet (part B).
To characterize prelamin A forms, we used selective antibodies: 1188-1 (directed to the full-length prelamin A-specific C-terminus sequence) detects both nonfarnesylated and farnesylated prelamin A, provided that the CSIM terminal sequence is maintained; 1188-2 (directed to the farnesylated prelamin A-specific C-terminus lacking the SIM sequence) detects farnesylated-carboxymethylated prelamin A. 4 1188-1 revealed intense fluorescence at low passage number in both normally shaped and dysmorphic nuclei indicating high levels of full-length prelamin A accumulation, while 1188-2 labelled only dysmorphic nuclei, suggesting that farnesylated-carboxymethylated prelamin A was less represented.
At high passage numbers, 1188-2 labelled the normally shaped nuclei, while both antibodies revealed intense fluorescence in highly dysmorphic enlarged nuclei (part C). 1188-1 and SC-6214, but not 1188-2, revealed the prelamin A normally shaped nuclei accumulating prelamin A, showed mostly unaffected tri-H3K9, which was only slightly more clustered in a low percentage of nuclei. Analogous alterations were revealed by tri-H4K20 labelling.
In conclusion, we detected significant changes in prelamin A levels and posttranslational modifications in all cell lines, depending on the passage number. So far, increased prelamin A levels have been observed in progeroid laminopathies, depending on the passage number or on the patient's age. 7, 12 We show that accumulation of full-length, farnesylated protein form prevails in RD fibroblasts, and that a subpopulation of cells accumulates high levels of both full-length and farnesylatedcarboxymethylated prelamin A. Finally, we demonstrate that accumulation of both forms is associated with the most severe abnormalities, i.e., nuclear enlargement and mis-shaping and severe chromatin defects. Our data suggest that the first cleavage step in prelamin A post-translational processing is mostly carried out by band in western blot analysis at low passages, confirming the small amount of farnesylated-carboxymethylated prelamin A (non-farnesylated, full-length prelamin A-accumulating control was obtained with Mevinolin 11 ). On the contrary, 1188-2 revealed a faint band in very high passage (p.25) cells, which did not accumulate the prelamin A form(s) detectable by 1188-1 or Sc-6214 (part C).
We then immunoprecipitated the whole prelamin A exploiting an anti-lamin A/C N-terminus antibody and revealed the immunoprecipitated bands with antiprelamin A or anti-farnesyl antibodies confirming farnesylation of prelamin A bands (panel D).
Searching for functional defects in RD nuclei, we labeled prelamin A and the heterochromatin marker tri-H3K9 or tri-H4K20. At any passage, dysmorphic nuclei accumulating both prelamin A forms, showed altered distribution (i.e., without clusters) or loss (in some nuclei) of tri-H3K9 fluorescence and disorganization of heterochromatic areas (part D); the ZMPSTE24 endoprotease, which is not efficiently replaced by other enzyme(s) in RD cells. However, our results suggest activation of alternative endoproteolytic processes, probably when high prelamin A levels are reached. 
